education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Fortusin
Fortusin
Manufacturer:
Solas
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Per 5 mL
Diphenhydramine HCl 5 mg, bromhexine HCl 4 mg, phenylephrine HCl 5 mg, Na citrate 25 mg, ammon Cl 62.5 mg, succus liquiritiae 180 mg
Indications/Uses
Allergic & productive cough, cough associated w/ flu & other resp disorders.
Dosage/Direction for Use
Adult & childn >12 yr
10 mL 3 times daily.
Childn 6-12 yr
5 mL 3 times daily.
Administration
Should be taken with food.
Contraindications
DM, CV disease.
Special Precautions
Hepatic & renal dysfunction, glaucoma, prostatic hypertrophy, hyperthyroidism. May impair ability to drive or operate machinery. Pregnancy & lactation. Childn <6 yr.
Adverse Reactions
Drowsiness, GI disturbances, insomnia, dry mouth, palpitation, urinary retention, excitation, arrhythmia, psychomotor disturbance.
View
ADR Reporting Link
Drug Interactions
Concomitant use w/ MAOIs causes HTN crisis.
MIMS Class
Cough & Cold Preparations
ATC Classification
R05CB02 - bromhexine ; Belongs to the class of mucolytics. Used in the treatment of wet cough.
Regulatory Classification
T
Presentation/Packing
Form
Fortusin syr
Packing/Price
120 mL x 1's (Rp29,500/botol);60 mL x 1's (Rp21,000/botol)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk